# XII Medical

> XII Medical is a Union City, California medical device company building a minimally invasive neuromodulation therapy for obstructive sleep apnea (OSA). Founded in 2017 and led by CEO Garrett Schwab, the company is developing an implantable platform designed to be smaller, more flexible and easier to implant than existing nerve-stimulation systems - an alternative for the estimated 425 million people worldwide with moderate-to-severe OSA who struggle with CPAP masks. Backed by Cleveland Clinic, Ajax Health, Omega Funds and Intuitive Ventures, XII Medical closed a $45M Series B in August 2024 to fund product and clinical development.

- **Founded:** 2017
- **Headquarters:** Union City, California, United States
- **Founders:** Garrett Schwab (President & CEO (since May 2021))
- **Team size:** ~37 employees
- **Products:** XII Medical Neuromodulation Platform
- **Notable:** Raised approximately $97 million in total venture funding across Series A and B., Secured Cleveland Clinic as a founding investor., Closed a $45 million Series B in August 2024 led by Omega Funds and Intuitive Ventures.

## Products & services

- **XII Medical Neuromodulation Platform** — An investigational, minimally invasive implantable neuromodulation (nerve stimulation) therapy for obstructive sleep apnea, designed with a streamlined surgical approach and a smaller, more flexible, easier-to-implant device than current solutions. Intended to increase upper-airway airflow during sleep. Currently limited to investigational use and not yet approved for sale.

## Achievements

- Raised approximately $97 million in total venture funding across Series A and B.
- Secured Cleveland Clinic as a founding investor.
- Closed a $45 million Series B in August 2024 led by Omega Funds and Intuitive Ventures.
- Built a differentiated, smaller and more flexible neuromodulation platform aimed at improving on existing implantable OSA therapies.

## Latest updates

- **2024-08** — Closed a $45 million Series B financing led by Omega Funds and Intuitive Ventures to advance product and clinical development.
- **2022-05** — Completed a $30 million Series A financing led by Ajax Health with co-lead Broadview Ventures and founding investor Cleveland Clinic.

## Links

- Website: https://xiimedical.com
- LinkedIn: https://www.linkedin.com/company/xii-medical

---

Profile page: https://yespress.io/xii-medical
Published by YesPress — https://yespress.io
Last updated: 2026-07-10